Bell Spring - Eucalyptus Oil
Natural health product licensed in Canada
- Other names
- Bell Spring - Eucalyptus, Bell Spring - Eucalyptus Essential Oil, Eucalyptus, Eucalyptus Essential Oil, Eucalyptus Oil
- Licence holder
- Arboland Wellness Inc.
- NPN or DIN-HM
- 80084586
- Status
- Inactive licence
- Licence date
- 19 April 2018
- Revision date
- Not provided
- Form
- Huile
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Eucalyptus globulus Source : Feuille | 100 % |
Non-medicinal ingredients
Not provided.
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | Not specified | Not specified |
Uses authorised in Canada
Used in aromatherapy to help relieve joint/muscle pain associated with sprain/strain/rheumatoid arthritis. Used in aromatherapy to help relieve headache. Used in aromatherapy to help relieve colds/cough.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
If you experience nausea, dizziness, headache or an allergic reaction, discontinue use.
- Contre-indications
If you are pregnant or breastfeeding, do not use this product. If you have broken, irritated, or sensitive skin, do not use this product.
- Précautions et mises en garde
Keep out of reach of children. If accidental ingestion occurs, seek urgent medical attention or contact a Poison Control Center. If symptoms persist or worsen, consult a health care practitioner. If you have epilepsy or asthma, consult a health care practitioner prior to use. Avoid exposure of applied area(s) to the sun.
Source
Official Health Canada record, licence 80084586
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.